Clinical Trials on Postmenopausal Breast Cancer

Total 55038 results

OHSU Knight Cancer Institute
Susan G. Komen Breast Cancer Foundation

Completed

Strength Training for Older Breast Cancer Survivors

Breast Neoplasm | Osteoporosis, Postmenopausal

United States
Mayo Clinic

Completed

Histology of Functional Density in Postmenopausal Breast

Breast Cancer | Dense Breasts

United States
Mayo Clinic

Completed

Histology of Functional Density in Premenopausal Breast

Breast Cancer | Dense Breasts

United States
National University Hospital, Singapore

Recruiting

Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START)

Advanced Refractory Solid Tumors | Advanced Triple Negative Breast Cancers | Metastatic Triple Negative Breast Cancers

Singapore
Hend Hamdy

Not yet recruiting

Effect of l S Exercises on Balance and Spatiotemporal Gait Parameters in P M Women

Postmenopausal
University of Erlangen-Nürnberg Medical School
Elsbeth-Bonhoff-Stiftung, Berlin

Terminated

Effects of Whole Body Vibration on Postmenopausal Risk-factors in Elderly Women

Postmenopausal

Germany
Warner Chilcott
Sanofi

Completed

Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMD

Postmenopausal

United States, Poland, Canada, Croatia, Netherlands
University Hospital Inselspital, Berne

Recruiting

Influence of Iyengar Yoga on the Bio-functional Age of Postmenopausal Women (IIYBFAPW)

Postmenopausal | Postmenopausal Flushing

Switzerland
Mayo Clinic

Completed

Remote Mindfulness-Based Physical Activity Intervention for Postmenopausal Women

Postmenopausal

United States
Cairo University

Recruiting

Body Balance Responses to Aquatic Therapy Among a Cohort of Healthy Postmenopausal Women

Postmenopausal Women

Egypt
Merck Sharp & Dohme LLC

Completed

A Clinical Study to Evaluate the Effects of Estrogen in Healthy Postmenopausal Women

Postmenopausal Symptoms
Warner Chilcott

Completed

Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate

Postmenopausal Women

United States
University of North Carolina, Chapel Hill
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Human Requirements for the Nutrient Choline

Postmenopausal Women

United States
Max-Planck-Institute of Psychiatry
Dr. Kade/Besins Pharma GmbH, Rigistr. 2, 12277 Berlin

Completed

Progesterone Reduces Wakefulness in Sleep EEG and Has no Effect on Cognition in Healthy Postmenopausal Women

Healthy | Postmenopausal

Germany
Riphah International University

Completed

High Intensity Multi-Modal Exercise Training in Postmenopausal Women (HIT-MMEX)

Postmenopausal Osteoporosis | Postmenopausal Osteopenia

Pakistan
Amgen

Completed

Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis

Postmenopausal Osteoporosis (PMO)

Japan
Deltanoid Pharmaceuticals

Completed

Safety Study of an Oral Vitamin D Analog in Postmenopausal Women

Postmenopausal Osteoporosis, Multiple Sites
Cairo University
faculty of physical therapy

Completed

Effect of Dash Diet and Acupuncture on Hypertention in Postmenopausal Women

Postmenopausal Disorder

Egypt
Chong Kun Dang Pharmaceutical
Severance Hospital

Completed

CKD-841 Pharmacokinetic/Pharmacodynamic Study

Postmenopausal Disorder

Korea, Republic of
University of Sao Paulo
AlzChem AG

Unknown

Creatine on Bone Mass in Postmenopausal Women

Postmenopausal Women

Brazil
Peking Union Medical College Hospital
Merck Serono International SA

Completed

Compare the Difference of P4 Concentration in Serum and Endometrium After Vaginal and IM P Administration

Postmenopausal Endometrium

China
Cairo University

Recruiting

Effect of Bioptron Light Therapy on Dryness of Eyes in Postmenopausal Women

Postmenopausal Women

Egypt
Fundación Santiago Dexeus Font

Completed

Relationship Between Homocysteine and BMD

Postmenopausal Women

Spain
Organon and Co

Completed

Tibolone Endometrium Study (Study 32972)(P06470) (THEBES)

Postmenopausal Women
Jae Hoon Lee
Gachon University Gil Medical Center; Daejeon University

Unknown

Efficacy and Safety of HPC-03 for Postmenopausal Symptom

Postmenopausal Period

Korea, Republic of
National Taiwan University Hospital

Completed

Physical Activity in Postmenopausal Women

Postmenopausal Disorder

Taiwan
Texas Tech University Health Sciences Center

Withdrawn

Tocotrienols for Skeletal Muscle Health (VitE-muscle)

Postmenopausal Women | Dynapenia

United States
Karadeniz Technical University

Completed

Raloxifene on Coagulation System in the Postmenopausal Women

Postmenopausal Women | Raloxifene
Chinese University of Hong Kong

Completed

Dose Finding Study of Danggui Buxue Tang (Herbal Formula)on the Treatment of Menopausal Symptoms

Postmenopausal

China
Weill Medical College of Cornell University
Avon Foundation

Completed

The Effect Of Meditation On Quality Of Life In Women With Breast Cancer And Other Gynecological Cancers

Gynecologic Cancer | Breast Cancers

United States
Jules Bordet Institute

Completed

Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers (MOMENTUM1)

Metastatic Colorectal Cancers | Metastatic Gastric Cancers | Metastatic Oesophageal Cancers | Metastatic Pancreatic Cancers | Metastatic Biliary Cancers | Metastatic Breast Cancers

Belgium
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey

Active, not recruiting

Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer

Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast Cancer

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Endoscopic Breast Surgery in Treating Patients With Breast Cancer

Male Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer

United States
University of Michigan
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Three Dimensional (3D) Ultrasound in Predicting Response to Breast Cancer Therapies

Breast Cancers

United States
University of Washington

Terminated

Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy

Breast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage IIB | Breast Cancer Stage IIA | Breast Cancer Stage IIIA | Breast Cancer Stage IIIB | Breast Cancer Stage IIIc

United States
Celgene

Completed

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) (tnAcity)

Breast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...

United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
University of Southern California
National Cancer Institute (NCI)

Terminated

PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer

HER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer

United States
University of Washington
National Cancer Institute (NCI)

Completed

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast...

United States
University of Campinas, Brazil

Unknown

Clinical Trial of Hysteroscopy in Postmenopausal Women to Compare Techniques

Hysteroscopy | Postmenopausal Women

Brazil
University of Washington
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer

HER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
Susan G. Komen Breast Cancer Foundation

Completed

Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer

Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast Cancer

United States
Northwestern University
Eisai Inc.

Unknown

Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients

Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...

United States
Ohio State University Comprehensive Cancer Center

Completed

Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast Cancer

Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Stage III Breast Cancer

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

High-Intensity Interval Training for Stage I-III Breast Cancer Patients

Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer

United States
Vardhman Mahavir Medical College And Safdarjung...

Completed

Clinicopathological Parameters of HER2 Low Breast Cancers

HER2 Low Breast Cancers

India
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Synta Pharmaceuticals Corp.; New York University...

Completed

Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer

HER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer

United States
University of California, Davis

Completed

Dried Cabernet Grapes and Cardiovascular Risk Markers (RZN)

Healthy, Postmenopausal Women

United States
Thar Pharmaceuticals, Inc

Completed

Open Label Dose Escalation Phase I Study to Investigate the Safety and Pharmacokinetics of T121E01F and T121E02F in Healthy Postmenopausal Women

Healthy Postmenopausal Women

United States
Novartis

Completed

Drug Interaction of SMC021 With Concomitant Antacid (Calcium Carbonate/Magnesium Hydroxide).

Health Postmenopausal Women

Denmark
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)

Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | Musculoskeletal Complications

United States

Clinical Trials on Postmenopausal Breast Cancer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations